Literature DB >> 27712927

Gut eradication of VIM-1 producing ST9 Klebsiella oxytoca after fecal microbiota transplantation for diarrhea caused by a Clostridium difficile hypervirulent R027 strain.

Sergio García-Fernández1, María-Isabel Morosini1, Marta Cobo1, José Ramón Foruny2, Antonio López-Sanromán2, Javier Cobo3, José Romero4, Rafael Cantón1, Rosa Del Campo5.   

Abstract

We report the fecal carriage eradication of a VIM-1-producing ST9 Klebsiella oxytoca strain in a pluripathological 84-year-old woman after fecal microbiota transplantation to control relapsing R027 hypervirulent Clostridium difficile infections. The donor was her son, in which the absence of fecal carbapenemase-producing bacteria was corroborated.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Carbapenemase eradication; Clostridium difficile infection; Eco-evo strategy; Fecal microbiota transplantation; Multidrug resistant bacteria

Mesh：

Substances：

Year:  2016        PMID： 27712927     DOI： 10.1016/j.diagmicrobio.2016.09.004

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  10 in total

1.  Efficacy and safety of fecal microbiota transplantation for decolonization of intestinal multidrug-resistant microorganism carriage: beyond Clostridioides difficile infection.

Authors:  Young Kyung Yoon; Jin Woong Suh; Eun-Ji Kang; Jeong Yeon Kim
Journal:  Ann Med       Date:  2019-09-13       Impact factor: 4.709

2.  The Use of Microbiome Restoration Therapeutics to Eliminate Intestinal Colonization With Multidrug-Resistant Organisms.

Authors:  Srinivasa Nithin Gopalsamy; Michael H Woodworth; Tiffany Wang; Cynthia T Carpentieri; Nirja Mehta; Rachel J Friedman-Moraco; Aneesh K Mehta; Christian P Larsen; Colleen S Kraft
Journal:  Am J Med Sci       Date:  2018-08-29       Impact factor: 2.378

3.  Fecal Microbiota Transfer for Multidrug-Resistant Gram-Negatives: A Clinical Success Combined With Microbiological Failure.

Authors:  Janneke E Stalenhoef; Elisabeth M Terveer; Cornelis W Knetsch; Peter J Van't Hof; Imro N Vlasveld; Josbert J Keller; Leo G Visser; Eduard J Kuijper
Journal:  Open Forum Infect Dis       Date:  2017-03-13       Impact factor: 3.835

4.  Characterization and formulation into solid dosage forms of a novel bacteriophage lytic against Klebsiella oxytoca.

Authors:  Teagan L Brown; Steve Petrovski; Dannielle Hoyle; Hiu Tat Chan; Peter Lock; Joseph Tucci
Journal:  PLoS One       Date:  2017-08-17       Impact factor: 3.240

Review 5.  Microbial approaches for targeting antibiotic-resistant bacteria.

Authors:  Wing Fei Wong; Marina Santiago
Journal:  Microb Biotechnol       Date:  2017-08-03       Impact factor: 5.813

Review 6.  Gut Microbiota Modulation for Multidrug-Resistant Organism Decolonization: Present and Future Perspectives.

Authors:  Livia Gargiullo; Federica Del Chierico; Patrizia D'Argenio; Lorenza Putignani
Journal:  Front Microbiol       Date:  2019-07-25       Impact factor: 5.640

7.  Fecal microbiota transplantation for treatment of recurrent C. difficile infection: An updated randomized controlled trial meta-analysis.

Authors:  Wenjia Hui; Ting Li; Weidong Liu; Chunyan Zhou; Feng Gao
Journal:  PLoS One       Date:  2019-01-23       Impact factor: 3.240

Review 8.  The potential utility of fecal (or intestinal) microbiota transplantation in controlling infectious diseases.

Authors:  Rohma Ghani; Benjamin H Mullish; Lauren A Roberts; Frances J Davies; Julian R Marchesi
Journal:  Gut Microbes       Date:  2022 Jan-Dec

9.  Fecal Microbiota Transplant for Refractory Clostridium difficile Infection Interrupts 25-Year History of Recurrent Urinary Tract Infections.

Authors:  Tiffany Wang; Colleen S Kraft; Michael H Woodworth; Tanvi Dhere; Molly E Eaton
Journal:  Open Forum Infect Dis       Date:  2018-01-15       Impact factor: 3.835

Review 10.  The Intestinal Microbiota as a Reservoir and a Therapeutic Target to Fight Multi-Drug-Resistant Bacteria: A Narrative Review of the Literature.

Authors:  Andrea Aira; Csaba Fehér; Elisa Rubio; Alex Soriano
Journal:  Infect Dis Ther       Date:  2019-10-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.